AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular
Key PointsInfrequent in CMML, AML-like mutations (CEBPA, FLT3, or NPM1) detect poor-prognosis CMML.
Key PointsInfrequent in CMML, AML-like mutations (CEBPA, FLT3, or NPM1) detect poor-prognosis CMML.
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
Obecabtagene autoleucel received approval from the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukemia…
In this issue of Blood, Kytölä et al demonstrate the utility of ex vivo drug-sensitivity testing for venetoclax to accurately predict response and overall
Key PointsThe 6-month cumulative incidence of hospitalization with infection was 18%; after this event, the 30-day mortality was 13%.All pneumocystosis occ
It has long been recognized that iron overload is toxic and that diagnosis and management of iron overload in patients with hematological disorders are com
Key PointsThere is an identifiable cohort of adults with SCD who have clinical encounters with documented respiratory symptoms without asthma.Intermittent
The COMMANDS trial evaluated frontline luspatercept in transfusion-dependent patients with lower-risk MDS and anemia.
This cohort study compares the long-term risk of colorectal cancer incidence and mortality among individuals receiving a negative colonoscopy screening result with those not undergoing…
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
Abstract. BACKGROUND: It is well established that alcohol use and chronic viral hepatitis negatively affect the peripheral platelet count. However, less is